LIVN Q4 2025 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$361M+12.1% YoY

Gross Profit

$240M66.4% margin

Operating Income

$43M11.8% margin

Net Income

$31M8.6% margin

EPS (Diluted)

$0.57

QoQ Revenue Growth

+0.9%

Cash Flow

Operating Cash Flow

$82M

Free Cash Flow

$50M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$1.4B

Stockholders' Equity

$1.2B

Cash & Equivalents

$636M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$361M	$322M	+12.1%
Gross Profit	$240M	$219M	+9.3%
Operating Income	$43M	$37M	+15.1%
Net Income	$31M	$56M	-44.8%

Revenue Segments

Cardiopulmonary Segment

$207M57%

Neuromodulation Segment

$153M43%

Geographic Segments

UNITED STATES

$191M53%

Locations Excluding The United States And Europe

$94M26%

Europe

$75M21%